October 25, 2018

FDA Okays First New Drug to Fight the Flu in Nearly 20 Years

FDA Approves New Med to Fight the Flu Forward to a friend | View Online
 
t.png p.png
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
FDA Okays First New Drug to Fight the Flu in Nearly 20 Years
FDA — The U.S. Food and Drug Administration has approved baloxavir marboxil (Xofluza) for acute influenza without complications in people 12 and over who've had flu symptoms for no more than 48 hours.
Read More »
Stress Linked to Memory Loss, Smaller Brain in Middle Age
Neurology — Adults in their 40s and 50s who have higher than normal levels of a hormone called cortisol that's linked to stress perform worse on memory and cognitive function tests and have smaller brain volumes.
Read More »
Common Blood Pressure Meds May Raise Lung Cancer Risk
BMJ — Results of a recent study suggest that blood pressure-lowering medications in the angiotensin converting enzyme inhibitor class (ACE inhibitors) may increase lung cancer risk compared to other antihypertensives.
Read More »
Inactivity Is Bad for People With Prediabetes
Berkeley Wellness — If you have prediabetes and become sidelined by illness, ask your doctor if you might benefit from dietary changes, active rehabilitation, or medication to keep your risk of diabetes in check.
Read More »
Advanced Prostate Cancer: The Basics
HealthCentral — Many treatments are now available that can help prolong survival in patients with metastatic disease. Here's what men with advanced prostate cancer and their loved ones should know.
Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523
More from Health Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523 imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=b6bd898523

No comments:

Post a Comment